Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Pfizer Investigational Site, Vienna

Pfizer Investigational Site, Vilnius

Pfizer Investigational Site, Mauer bei Amstetten

Pfizer Investigational Site, Berlin

Pfizer Investigational Site, Marseille

Pfizer Investigational Site, Marseille

Pfizer Investigational Site, Berlin

Pfizer Investigational Site, Girona

Pfizer Investigational Site, Donostia / San Sebastian

Pfizer Investigational Site, Madrid

Pfizer Investigational Site, Madrid

Pfizer Investigational Site, Colomiers

Pfizer Investigational Site, Bielefeld

Pfizer Investigational Site, Montpellier

Pfizer Investigational Site, Rennes

Pfizer Investigational Site, Marburg

Pfizer Investigational Site, Essen

Pfizer Investigational Site, Florence

Pfizer Investigational Site, Siena

Pfizer Investigational Site, Bonn

Pfizer Investigational Site, Dommartin-lès-Toul

Pfizer Investigational Site, Pisa

Pfizer Investigational Site, Lille

Pfizer Investigational Site, Frankfurt

Pfizer Investigational Site, Strasbourg

Pfizer Investigational Site, Paris

Pfizer Investigational Site, Kehl

Pfizer Investigational Site, Freiburg im Breisgau

Pfizer Investigational Site, Ulm

Pfizer Investigational Site, Innsbruck

Pfizer Investigational Site, Sankt Pölten

Pfizer Investigational Site, Calgary

Pfizer Investigational Site, Edmonton

Pfizer Investigational Site, Vancouver

Pfizer Investigational Site, Halifax

Pfizer Investigational Site, Barrie

Pfizer Investigational Site, London

Pfizer Investigational Site, Ottawa

Pfizer Investigational Site, Trois-Rivières

Pfizer Investigational Site, Göttingen

Pfizer Investigational Site, Perugia

Pfizer Investigational Site, Vilnius

Pfizer Investigational Site, Barcelona

Pfizer Investigational Site, Glascow

Pfizer Investigational Site, Fazakerley, Liverpool

Pfizer Investigational Site, York

Pfizer Investigational Site